Organization
University of Hong Kong
8 abstracts
Abstract
Clinical and analytical validation of a targeted gene expression biomarker predicting meningioma outcomes and radiotherapy responses.Org: University of California-San Francisco, University of Chicago Medical Center, Chicago, IL, University of California San Francisco, University Clinic of Heidelberg, UCSF Department of Radiation Oncology,
Abstract
The TAC-GReD trial: The combination of talazoparib and carboplatin in DNA damage repair deficient recurrent high-grade glioma.Org: Department of Clinical Oncology, Queen Elizabeth Hospital, LKS Faculty of Medicine, University of Hong Kong, Department of Neurosurgery, Prince of Wales Hospital, Prince of Wales Hospital,
Abstract
The efficacy of radical hepatectomy versus stereotactic body radiotherapy for primary hepatocellular carcinoma: A propensity score matching analysis.Org: University of Hong Kong, University of Hong Kong-Shenzhen Hospital, Shenzhen University General Hospital,
Abstract
Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced, unresectable hepatocellular carcinoma (START-FIT using STRIDE): A single-arm, phase II study.Org: The University of Hong Kong, The Chinese University of Hong Kong, Department of Clinical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Tuen Mun Hospital, University of Hong Kong,
Abstract
Perioperative IDO-1 dynamic changes in NSCLC patients.Org: The University of HongKong-Shenzhen Hospital, University of Hong Kong, The University of Hong Kong-Shenzhen Hospital, Shenzhen TargetRx, The University of Hong Kong,
Abstract
Single-cell and spatial transcriptomics to analyze radiation therapy-induced tumor microenvironment reshaping in HPV- cervical cancer.Org: Hong Kong University of Shenzhen Hospital, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, The University of Hong Kong, University of Hong Kong, Department of Clinical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University,
Abstract
Revealing a novel tumor immune escaping mechanism induced by macrophage-tumor fusion cells in HPV- cervical cancer through spatial SCRNA analysis.Org: Hong Kong University of Shenzhen Hospital, Department of Clinical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, The University of Hong Kong-Shenzhen Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Southern University of Science and Technology,
Abstract
A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritisOrg: Northwell Health, New Hyde Park, NY, University of North Carolina at Chapel Hill, University of California San Francisco, Keio University School of Medicine, Hospital Fernández,